Tests Showing Smokers Their Individual Risk Of Future Disease Will Help Them Quit, Says Paper

Personalizing Risk To Prompt Lifestyle Changes Good Model For Improving Smoking Cessation

Research Shows Efforts To Quit Smoking Strengthen After Personalized Lung Cancer Risk Test

HOUSTON, Dec. 8 - Smokers who see their own personal risk of developing lung cancer after genetic-based testing show stronger intention and take more action on quitting smoking, according to cli...

Personalized, Gene-Based Risk Testing For Lung Cancer Gives New Tool To Help Smokers Quit

Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.

Synergenz reviews “Questioning a Cancer Test”, a New York Times article (November 7, 2009) about RespirageneTM

Christopher Taylor's story tells it all. Here is a man who smoked but wanted to quit. Like many smokers, Taylor was interested in better understanding his own risk profile for lung cancer throug...

Gauging the Risks From a Smoker’s DNA and History (The New York Times)

To take Synergenz’s RespirageneTM test, consumers swab the inside of a cheek to get DNA and send the sample to a laboratory in Kentucky.

Questioning a Test for Lung Cancer (The New York Times)

Christopher Taylor says he never lasted more than a week when he tried to quit smoking in the past. But it has been four weeks and counting this time, since a genetic test indicated he had a much higher risk of developing lung cancer than the average smoker.